Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic Purpura

Arteriosclerosis, Thrombosis, and Vascular Biology
Claudia TersteegKaren Vanhoorelbeke

Abstract

The metalloprotease ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) regulates the size of von Willebrand factor multimers. A deficiency in ADAMTS13 activity is associated with the life-threatening disease thrombotic thrombocytopenic purpura (TTP). The vast majority of patients have acquired TTP, where circulating anti-ADAMTS13 autoantibodies are causative for the decreased ADAMTS13 activity. Current treatment consists of plasma exchange, but improved therapies are highly warranted. We have developed a new rat model mimicking various aspects of acquired TTP to investigate the therapeutic efficacy of human recombinant ADAMTS13. A polyclonal antibody against ADAMTS13 completely blocked endogenous rat ADAMTS13 activity in Sprague-Dawley rats. When TTP was triggered using recombinant von Willebrand factor, the animals displayed severe TTP-like symptoms, such as thrombocytopenia, hemolytic anemia, and von Willebrand factor-rich thrombi in the kidneys and brain. Subsequent injection of 400, 800, or 1600 U/kg recombinant ADAMTS13 prevented full development of these symptoms. Analysis of plasma samples confirmed that recombinant ADAMTS13 was able to override circulating anti-ADAMTS13 inhibito...Continue Reading

References

Nov 26, 1998·The New England Journal of Medicine·H M Tsai, E C Lian
Aug 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Koichi KokameYoshihiro Fujimura
Jan 17, 2004·Seminars in Hematology·Barbara Plaimauer, Friedrich Scheiflinger
Aug 12, 2005·Current Opinion in Hematology·Spero R Cataland, Haifeng M Wu
Oct 1, 2005·Journal of Thrombosis and Haemostasis : JTH·C J SchootenC V Denis
Jan 27, 2011·The Journal of Clinical Investigation·Junmei ChenJosé A López
Jul 17, 2013·Journal of Thrombosis and Haemostasis : JTH·K Vanhoorelbeke, S F De Meyer
Oct 15, 2013·Journal of Clinical Apheresis·Jay S RavalJoseph E Kiss
Feb 14, 2014·Journal of Blood Medicine·Piers Blombery, Marie Scully

❮ Previous
Next ❯

Citations

Jun 9, 2016·Expert Review of Hematology·Katerina PavenskiKaren Vanhoorelbeke
Jan 11, 2017·Journal of Blood Transfusion·Jason P AckerWilliam P Sheffield
Jul 1, 2017·Journal of Thrombosis and Haemostasis : JTH·M SahaX L Zheng
Jun 26, 2018·Lab on a Chip·Keith H K WongMehmet Toner
Jun 20, 2018·Clinical and Experimental Pharmacology & Physiology·Jing LingShaoyan Hu
Jul 27, 2018·Research and Practice in Thrombosis and Haemostasis·Camila Masias, Spero R Cataland
Sep 22, 2017·PLoS Neglected Tropical Diseases·Rahajeng N TunjungputriQuirijn de Mast
Jan 18, 2018·Journal of Thrombosis and Haemostasis : JTH·M LeviM Singer
Jul 26, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Reheman Adili, Michael Holinstat
Jul 31, 2019·Expert Opinion on Biological Therapy·Maëlle le BesneraisPaul Coppo
Jan 29, 2020·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Femie ChauvelOlivier Moranne
Aug 2, 2017·Current Opinion in Hematology·Yvette C TanhehcoAra Metjian
Jul 7, 2020·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·A D MakatsariyaT Mashkova
Apr 7, 2017·Nature Reviews. Disease Primers·Johanna A Kremer HovingaKaren Vanhoorelbeke
Apr 4, 2020·Expert Review of Hematology·Andrés Gómez-De LeónDavid Gómez-Almaguer
May 18, 2019·Journal of Thrombosis and Haemostasis : JTH·Sirima KraisinSimon F De Meyer
Jun 18, 2017·Frontiers in Immunology·Ralf J LudwigFalk Nimmerjahn
Jul 28, 2017·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Damien G NooneChristoph Licht
Mar 5, 2019·British Journal of Haematology·Marie Scully, Marcel Levi
May 30, 2019·Journal of Intensive Care·Toshiaki IbaHideo Wada
Nov 7, 2017·Journal of Thrombosis and Haemostasis : JTH·K South, D A Lane
Mar 29, 2021·Journal of Thrombosis and Haemostasis : JTH·Dafna J GroeneveldJames P Luyendyk
Sep 1, 2021·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·P Poullin
Sep 18, 2021·Clinical Science·Erika I Boesen, Rahul M Kakalij

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.